LUMICELL, INC.

Profile

Company Names

LUMICELL, INC.
LUMICELL DIAGNOSTICS, INC.

Addresses

275 WASHINGTON STREET, STE. 200, NEWTON, MA 02458

275 WASHINGTON ST., STE. 200, NEWTON, MA 02458

80 WILLIAM STREET, STE. 260, WELLESLEY, MA 02481

1000 WINTER STREET, STE. 3800, WALTHAM, MA 02451

Phone Numbers

617-404-1001
781-684-0244

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$331,090,215.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2025-04-22 
$198,128,718.00 
INDEFINITE 
INDEFINITE 
Equity 
8
2024-07-11 
$2,730,612.00 
$12,000,000.00 
$9,269,388.00 
Equity, Debt 
7
2024-02-22 
$2,275,000.00 
INDEFINITE 
INDEFINITE 
Equity, Debt 
6
2023-07-14 
$75,843,150.00 
$110,204,111.00 
$34,360,961.00 
Equity 
5
2018-12-07 
$20,365,906.00 
$35,000,004.00 
$14,634,098.00 
Equity 
4
2017-06-28 
$20,705,024.00 
$26,505,014.00 
$5,799,990.00 
Equity 
3
2016-04-20 
$6,769,997.00 
$10,000,000.00 
$3,230,003.00 
Equity 
2
2013-12-19 
$1,563,572.00 
$1,563,572.00 
$0.00 
Equity 
1
2011-05-18 
$2,708,236.00 
$3,908,237.00 
$1,200,001.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JAMES 
 
ALECXIH 
DIRECTOR
MOUNGI 
 
BAWENDI 
DIRECTOR
JORGE 
 
FERRER 
EXECUTIVE OFFICER
COSIMO 
 
FIORENZA 
DIRECTOR
DAVID 
 
FURNEAUX 
DIRECTOR
HOWARD 
 
HECHLER 
EXECUTIVE OFFICER, DIRECTOR
KEVIN 
 
HERSHBERGER 
EXECUTIVE OFFICER, DIRECTOR
WILLIAM 
D. 
JOHNSON 
EXECUTIVE OFFICER
KEVIN 
 
KRENITSKY 
DIRECTOR
W. 
DAVID 
LEE 
EXECUTIVE OFFICER, DIRECTOR
KELLY 
 
LONDY 
EXECUTIVE OFFICER, DIRECTOR
MICHAEL 
 
RUETTGERS 
DIRECTOR
MIKE 
 
RUETTGERS 
DIRECTOR
JAMES 
 
SCHUERMANN 
DIRECTOR
RALPH 
 
WEISSLEDER 
DIRECTOR
ANDREY 
J. 
ZARUR 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-04-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2024-07-11 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2024-02-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-07-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-06-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-20 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NETWORK 1 FINANCIAL SECURITIES INC.
NONE
NONE
NETWORK FINANCIAL SECURITIES INC.